Symbol="EQ"
AssetType="Common Stock"
Name="Equillium Inc"
Description="Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California."
CIK="1746466"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="27015100"
EBITDA="-28731000"
PERatio="None"
PEGRatio="None"
BookValue="0.928"
DividendPerShare="0"
DividendYield="0"
EPS="-0.72"
RevenuePerShareTTM="0.467"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.247"
ReturnOnEquityTTM="-0.707"
RevenueTTM="24638000"
GrossProfitTTM="15759000"
DilutedEPSTTM="-0.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.488"
EVToRevenue="-"
EVToEBITDA="-0.121"
Beta="1.248"
num_52WeekHigh="3.2"
num_52WeekLow="0.48"
num_50DayMovingAverage="0.765"
num_200DayMovingAverage="0.966"
SharesOutstanding="34414100"
DividendDate="None"
ExDividendDate="None"
symbol="EQ"
open="0.81"
high="0.81"
low="0.73"
price="0.74"
volume="208937.00"
latest_trading_day="2023-08-15"
previous_close="0.79"
change="-0.05"
change_percent="-5.9618%"
aroon_positive_momentum_days="39"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="197180"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0062.jpeg"
image_negative_thumbnail_id_2="104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0072.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="700"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
